- The Oracle of Omaha, Warren Buffett, has increased his portfolio's exposure to Bitcoin-friendly companies like Nubank.
- Based on a recent SEC filing, Berkshire Hathaway dumped Visa and Mastercard stocks in favor of Nubank, a Brazilian neobank.
- The firm purchased $1 billion worth of Nubank shares in Q4 2021.
American business magnate Warren Buffett's firm Berkshire Hathaway sold Visa and Mastercard stocks and increased exposure in the most prominent Brazilian fintech bank, Nubank. Buffett has addressed Bitcoin as "rat poison squared," however the latest SEC filing reveals his interest in BTC-friendly companies.
Berkshire Hathaway added $250 million in Nubank shares in Q4 2021
Warren Buffett's firm Berkshire Hathaway sold payment giant Visa and Mastercard stocks to acquire 40 million Nubank shares worth $1 billion in Q4 2021. Nubank is Brazil's largest fintech bank, a Bitcoin-friendly firm, popular among investors.
In a Securities & Exchange Commission (SEC) filing on February 14, Berkshire Hathaway disclosed the purchase of Nubank's Class A stocks. The firm sold $3.1 billion in Visa and Mastercard stocks, reducing exposure to credit companies.
Buffett is best known for his critique of Bitcoin; the business magnate used the term "rat poison squared" to describe the cryptocurrency. Despite the veteran investors' approach to Bitcoin, there is a rise in Berkshire Hathaway's exposure to BTC-friendly firms and institutions.
Nubank is a fintech bank that allows users to invest in cryptocurrency ETFs, and Berkshire Hathaway has no intention of reducing exposure to the firm. Berkshire Hathaway's recent investment decisions show the acknowledgment of the rise in Bitcoin mainstream acceptance and adoption.
Fintech companies have added Bitcoin to their balance sheet or rapidly offered related services to users over the past two years, as the asset gained higher popularity. Berkshire Hathaway's willingness to associate with a Bitcoin-friendly fintech giant fuels a bullish narrative for Bitcoin price.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended Content
Editors’ Picks
Ripple wipes out weekly gains, experts comment on role of Ripple stablecoin
Ripple declined to $0.52 on Thursday, erasing all gains registered earlier this week. Ripple SVP Eric van Miltenburg’s comments on the firm’s stablecoin, and how it is expected to benefit the XRP Ledger and native token XRP have raised concerns among crypto experts.
Hedera HBAR slips nearly 10% after air is cleared on mistaken link with giant BlackRock
HBAR price is down nearly 10% on Thursday, partly erasing gains inspired by the misinterpreted link with BlackRock. Despite the recent correction, Hedera’s price is up 44% in the past seven days.
The reason behind Bonk’s 105% rise and if you should buy now Premium
Bonk price has shot up 105% in the past five weeks. A retracement into $0.0000216 or the $0.0000152 to $0.0000186 imbalance would be a good buying opportunity. Patient investors can expect double-digit gains from BONK that could extend up to 70%.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.
Bitcoin: BTC post-halving rally could be partially priced in Premium
Bitcoin (BTC) price briefly slipped below the $60,000 level for the last three days, attracting buyers in this area as the fourth BTC halving is due in a few hours. Is the halving priced in for Bitcoin? Or will the pioneer crypto note more gains in the coming days?